lithium carbonate has been researched along with Disease Models, Animal in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.63) | 18.7374 |
1990's | 3 (7.89) | 18.2507 |
2000's | 13 (34.21) | 29.6817 |
2010's | 18 (47.37) | 24.3611 |
2020's | 3 (7.89) | 2.80 |
Authors | Studies |
---|---|
Bekar, LK; Pacholko, AG | 1 |
Gao, T; Guan, Z; Guo, J; Li, S; Liu, Y; Luo, D; Lyu, J; Niu, B; Qin, J; Wang, F; Wang, J; Wang, X; Yang, Y; Yue, H; Zhang, F; Zhang, T; Zhong, R | 1 |
Abdel Latif, NS; El-Kalaawy, AM; Lamie, PF; Philoppes, JN; Rashed, LA | 1 |
Biagioni, F; Busceti, CL; Calierno, MT; Ferrucci, M; Fornai, F; Fulceri, F; Lazzeri, G; Ruffoli, R; Ryskalin, L | 1 |
Andreatini, R; de Souza, CP; Dornellas, APS; Ferreira, ST; Galduróz, JCF; Santos, LE; Schwarting, RKW; Wendler, E; Wöhr, M | 1 |
Goel, RK; Ivanov, S; Kumar, S; Lagunin, A | 1 |
Albayrak, A; Atamanalp, SS; Bayir, Y; Cadirci, E; Halici, Z; Karakus, E; Karcioglu, SS; Kunak, S; Polat, B; Unal, D; Yigit, S | 1 |
Jun, AS; Kim, EC; Meng, H | 1 |
Andreatini, R; Brenes, JC; Pereira, M; Schwarting, RK | 1 |
Akimana, G; Barbelivien, A; Cassel, JC; Cosquer, B; Faure, JB; Ferrandon, A; Herbeaux, K; Koning, E; Marques-Carneiro, JE; Nehlig, A | 1 |
Chevillard, L; El Balkhi, S; Hanak, AS; Mégarbane, B; Peoc'h, K; Risède, P | 1 |
Albuquerque, MS; Balthazar, J; Baraldi-Tornisielo, T; Buck, HS; Caetano, AL; Monteiro-Silva, KC; Nunes, MA; Schöwe, NM; Souza, SI; Viel, TA | 1 |
Bedford, JJ; Kalita-De Croft, P; Leader, JP; Walker, RJ | 1 |
Ben Saad, A; Brahmi, D; Ncib, S; Rjeibi, I; Smida, A; Zouari, N; Zourgui, L | 1 |
Andreatini, R; de Almeida Soares Hocayen, P; de Souza, CP; Kanazawa, LKS; Schwarting, RKW; Vecchia, DD; Wendler, E; Wöhr, M | 1 |
Andreatini, R; Baretta, IP; Gustafson, L; Ninomiya, EM; Rodrigues, AL; Sabioni, P | 1 |
DiazGranados, N; Zarate, CA | 1 |
Ardalan, FA; Bahadori, M; Behfar, B; Dehpour, AR; Moezi, L; Paragomi, P; Paydar, MJ; Shamshiri, H | 1 |
Bendotti, C; Caron, I; Carrì, MT; Daleno, C; Minoia, C; Pizzasegola, C; Ronchi, A | 1 |
Gill, A; Kidd, J; Perrin, S; Thompson, K; Vieira, F | 1 |
Ando, K; Authelet, M; Boeynaems, JM; Brion, JP; Buée, L; De Decker, R; Héraud, C; Leroy, K; Yilmaz, Z | 1 |
Dehpour, AR; Fakhfouri, G; Mehr, SE; Rahimian, R; Rasouli, MR; Tavangar, SM | 1 |
Chuang, DM; Liu, ZH; Smith, CB | 1 |
Beurel, E; Jope, RS; Yuskaitis, CJ | 1 |
Eblen-Zajjur, A; Wix-Ramos, R | 1 |
Cryan, JF; Dinan, TG; O'Leary, OF; Zandy, S | 1 |
Parthasarathy, LK; Parthasarathy, RN; Seelan, RS; Vadnal, RE; Wilson, MA | 1 |
O'Neill, HC; Schmitt, MP; Stevens, KE | 1 |
Keshavan, V; Shanthi, M; Tyagi, MG; Vikram, GS | 1 |
Kasahara, T; Kato, T; Kubota, M; Miyauchi, T; Mouri, A; Nabeshima, T; Noda, Y | 1 |
Bardini, K; Dal-Pizzol, F; Frey, BN; Kapczinski, F; Martins, MR; Petronilho, FC; Quevedo, J; Réus, GZ; Valvassori, SS | 1 |
Cho, SI; Gwag, BJ; Joo, IS; Kim, KW; Lee, JK; Lee, YA; Lim, HR; Noh, JS; Shin, JH | 1 |
Bedford, JJ; Jing, R; Klein, JD; Leader, JP; Sands, JM; Walker, LJ; Walker, RJ | 1 |
Concannon, JT; Schechter, MD | 1 |
Aulakh, CS; Hill, JL; Murphy, DL | 1 |
Thompson, K; Wasterlain, C | 1 |
Chalecka-Franaszek, E; Chen, RW; Chuang, DM; Hashimoto, R; Hiroi, T; Hough, C; Kanai, H; Leeds, P; Ren, M; Senatorov, V | 1 |
Keck, PE; McElroy, SL; Pope, HG; Seeler, DC | 1 |
2 review(s) available for lithium carbonate and Disease Models, Animal
Article | Year |
---|---|
A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder.
Topics: Adult; Animals; Antimanic Agents; Bipolar Disorder; Brain; Controlled Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Therapy, Combination; Drugs, Investigational; Female; Humans; Lithium Carbonate; Male; Protein Kinase C; Tamoxifen; Valproic Acid | 2008 |
Neuroprotective effects of lithium in cultured cells and animal models of diseases.
Topics: Animals; Bipolar Disorder; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Glutamic Acid; Lithium Carbonate; Neurons; Receptors, N-Methyl-D-Aspartate; Stroke | 2002 |
36 other study(ies) available for lithium carbonate and Disease Models, Animal
Article | Year |
---|---|
Different pharmacokinetics of lithium orotate inform why it is more potent, effective, and less toxic than lithium carbonate in a mouse model of mania.
Topics: Amphetamine; Animals; Antimanic Agents; Bipolar Disorder; Disease Models, Animal; Female; Lithium; Lithium Carbonate; Male; Mania; Mice | 2023 |
Neural tube defects: role of lithium carbonate exposure in embryonic neural development in a murine model.
Topics: 5'-Nucleotidase; Animals; Central Nervous System; Disease Models, Animal; Female; Glycogen Synthase Kinase 3 beta; Inositol; Lithium Carbonate; Maternal Exposure; Mice; Mice, Inbred C57BL; Neural Tube Defects; Pregnancy | 2021 |
Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure-activity relationship and biological activity as potential antitumor and anticonvulsant agents.
Topics: Animals; Anticonvulsants; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Lithium Carbonate; Male; Mice; Molecular Structure; Pilocarpine; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Receptor, ErbB-2; Status Epilepticus; Structure-Activity Relationship | 2021 |
Protective effects of long-term lithium administration in a slowly progressive SMA mouse model.
Topics: Animals; Disease Models, Animal; Humans; Lithium Carbonate; Mice; Mice, Knockout; Mice, Transgenic; Motor Neurons; Neuroprotective Agents; Spinal Cord; Spinal Muscular Atrophies of Childhood | 2017 |
Mania-like elevated mood in rats: Enhanced 50-kHz ultrasonic vocalizations after sleep deprivation.
Topics: Animals; Antimanic Agents; Biogenic Monoamines; Bipolar Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Lithium Carbonate; Locomotion; Male; Maternal Behavior; Rats; Rats, Wistar; Sleep Deprivation; Time Factors; Ventral Striatum; Vocalization, Animal | 2019 |
Glycogen synthase kinase-3 inhibition as a potential pharmacological target for vascular dementia: In silico and in vivo evidence.
Topics: Animals; Computer Simulation; Dementia, Vascular; Disease Models, Animal; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Lithium Carbonate; Mice | 2019 |
Protective effects of lithium: a new look at an old drug with potential antioxidative and anti-inflammatory effects in an animal model of sepsis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Dinoprost; Disease Models, Animal; Glutathione; Lithium Carbonate; Male; Rats; Rats, Wistar; Sepsis; Superoxide Dismutase | 2013 |
Lithium treatment increases endothelial cell survival and autophagy in a mouse model of Fuchs endothelial corneal dystrophy.
Topics: Animals; Apoptosis; Blotting, Western; Cattle; Cell Count; Cell Survival; Cells, Cultured; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Endothelium, Corneal; Fuchs' Endothelial Dystrophy; Gene Expression Regulation; Heat-Shock Proteins; Hydrogen Peroxide; Lithium Carbonate; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Microscopy, Electron, Transmission; Oxidative Stress; Real-Time Polymerase Chain Reaction; Thapsigargin; Transcription Factor CHOP | 2013 |
Amphetamine-induced appetitive 50-kHz calls in rats: a marker of affect in mania?
Topics: Animals; Antimanic Agents; Bipolar Disorder; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Flavonoids; Lithium Carbonate; Male; Motor Activity; Protein Kinase C; Rats; Rats, Wistar; Signal Transduction; Tamoxifen; Vocalization, Animal | 2014 |
Attention and executive functions in a rat model of chronic epilepsy.
Topics: Animals; Anticonvulsants; Attention; Brain; Brain Mapping; Carbamates; Cell Count; Disease Models, Animal; Epilepsy, Complex Partial; Epilepsy, Temporal Lobe; Executive Function; Inhibition, Psychological; Lithium Carbonate; Neurons; Pattern Recognition, Visual; Pilocarpine; Rats; Rats, Sprague-Dawley; Reaction Time; Serial Learning; Status Epilepticus | 2014 |
Study of blood and brain lithium pharmacokinetics in the rat according to three different modalities of poisoning.
Topics: Acute Disease; Animals; Area Under Curve; Brain; Chronic Disease; Disease Models, Animal; Drug Administration Schedule; Erythrocytes; Half-Life; Injections, Intraperitoneal; Lithium Carbonate; Male; Metabolic Clearance Rate; Models, Biological; Neurotoxicity Syndromes; Poisoning; Potassium Dichromate; Rats, Sprague-Dawley; Renal Insufficiency | 2015 |
Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.
Topics: Administration, Oral; Alzheimer Disease; Amnesia; Animals; Avoidance Learning; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Drug Administration Schedule; Gene Expression; Hippocampus; Humans; Lithium Carbonate; Locomotion; Male; Maze Learning; Memory; Mice; Mice, Transgenic; Neuroprotective Agents; Plaque, Amyloid | 2015 |
Amiloride modifies the progression of lithium-induced renal interstitial fibrosis.
Topics: Amiloride; Animals; beta Catenin; Collagen Type III; Connective Tissue Growth Factor; Cytoprotection; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Disease Progression; Epithelial Sodium Channel Blockers; Fibrosis; Glycogen Synthase Kinase 3 beta; Kidney; Kidney Diseases; Lithium Carbonate; Male; Myofibroblasts; Rats, Wistar; Transforming Growth Factor beta1 | 2018 |
Malva sylvestris extract protects upon lithium carbonate-induced kidney damages in male rat.
Topics: Animals; Antioxidants; Biomarkers; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Flavonoids; Hydroxybenzoates; Kidney; Kidney Diseases; Lipid Peroxidation; Lithium Carbonate; Male; Malva; Oxidative Stress; Phytotherapy; Plant Extracts; Plant Leaves; Plants, Medicinal; Rats, Wistar; Time Factors | 2016 |
Evaluation of 50-kHz ultrasonic vocalizations in animal models of mania: Ketamine and lisdexamfetamine-induced hyperlocomotion in rats.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Central Nervous System Stimulants; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hyperkinesis; Ketamine; Lisdexamfetamine Dimesylate; Lithium Carbonate; Male; Motor Activity; Rats; Rats, Wistar; Vocalization, Animal | 2016 |
The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs.
Topics: Amphetamine; Analysis of Variance; Animals; Antimanic Agents; Behavior, Animal; Benzophenanthridines; Contraceptives, Oral, Synthetic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Hyperkinesis; Lithium Carbonate; Medroxyprogesterone; Mice; Protein Kinase C; Tamoxifen | 2008 |
Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway.
Topics: Administration, Oral; Analgesics; Animals; Colon; Defecation; Diarrhea; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Guanidines; Hyperalgesia; Injections, Intraperitoneal; Irritable Bowel Syndrome; Lithium Carbonate; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pain Measurement; Pain Threshold; Pressure; Rats; Rats, Wistar; Rectum; Restraint, Physical; Stress, Psychological | 2009 |
Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antimanic Agents; Behavior, Animal; Biomarkers; Body Weight; Disease Models, Animal; Disease Progression; Female; Humans; Lithium Carbonate; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenotype; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Survival Rate | 2009 |
No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Body Weight; Disease Models, Animal; Female; Humans; Lithium Carbonate; Male; Mice; Proportional Hazards Models; Severity of Illness Index; Survival Analysis | 2009 |
Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
Topics: Age Factors; Analysis of Variance; Animals; Antibodies, Monoclonal; Antimanic Agents; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Glycogen Synthase Kinase 3; Humans; Immunoprecipitation; Lithium Carbonate; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Motor Activity; Mutation; Nerve Tissue Proteins; Neurofibrillary Tangles; Phosphorylation; Proto-Oncogene Proteins c-akt; Sciatic Nerve; Spinal Cord; tau Proteins; Tauopathies | 2010 |
Lithium does not protect against spinal cord ischemia-reperfusion injury in rabbits.
Topics: Animals; Apoptosis; Disease Models, Animal; In Situ Nick-End Labeling; Lithium Carbonate; Neurologic Examination; Neuroprotective Agents; Rabbits; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia | 2010 |
Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.
Topics: Animals; Anxiety; Behavior, Animal; Body Weight; Dendritic Spines; Disease Models, Animal; Enzyme Inhibitors; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; Genotype; Humans; Lithium Carbonate; Male; Maze Learning; Mice; Mice, Knockout; Motor Activity; Prefrontal Cortex | 2011 |
Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome.
Topics: Animals; Astrocytes; Brain; Cytokines; Disease Models, Animal; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; Glial Fibrillary Acidic Protein; Glycogen Synthase Kinase 3; Immune System; Immunoblotting; Lithium Carbonate; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Phosphorylation; Serine; Testis | 2010 |
Time course of acute neuroprotective effects of lithium carbonate evaluated by brain impedanciometry in the global ischemia model.
Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Impedance; Humans; Infusions, Intravenous; Lithium Carbonate; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Time Factors | 2011 |
Lithium augmentation of the effects of desipramine in a mouse model of treatment-resistant depression: a role for hippocampal cell proliferation.
Topics: Animals; Cell Proliferation; Depressive Disorder, Treatment-Resistant; Desipramine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hippocampus; Lithium Carbonate; Male; Mice; Mice, Inbred BALB C; Treatment Outcome | 2013 |
Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.
Topics: Administration, Oral; Animals; Antimanic Agents; Bipolar Disorder; Blotting, Western; Brain; Disease Models, Animal; Drug Administration Schedule; Lithium Carbonate; Phosphoric Monoester Hydrolases; Rats; Rats, Sprague-Dawley; Signal Transduction | 2003 |
Lithium alters measures of auditory gating in two strains of mice.
Topics: Animals; Antipsychotic Agents; Auditory Perceptual Disorders; Cholinergic Fibers; Disease Models, Animal; Evoked Potentials, Auditory; gamma-Aminobutyric Acid; Lithium Carbonate; Male; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Receptors, Nicotinic | 2003 |
Phospholipid mediators and MgATPase modulation causes changes in the cardiovascular effects of vasopressin in lithium carbonate-induced polyuric rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Ca(2+) Mg(2+)-ATPase; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Heart Rate; Injections, Intraperitoneal; Injections, Intravenous; Lithium Carbonate; Lypressin; Mice; Motor Activity; Neomycin; Phospholipids; Piperidines; Polyuria; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Sphingosine | 2004 |
Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes.
Topics: Animals; Antidepressive Agents, Tricyclic; Antimanic Agents; Behavior, Animal; Circadian Rhythm; Disease Models, Animal; DNA Polymerase gamma; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Female; Gene Deletion; Lithium Carbonate; Male; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Mood Disorders; Motor Activity; Neurons; Ophthalmoplegia, Chronic Progressive External; Phenotype; Prosencephalon | 2006 |
Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.
Topics: Animals; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Catalase; Dextroamphetamine; Disease Models, Animal; Drug Interactions; Hippocampus; Lipid Peroxidation; Lithium Carbonate; Male; Motor Activity; Oxidative Stress; Prefrontal Cortex; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Valproic Acid | 2006 |
Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Apoptosis; Benzoates; Cell Survival; Disease Models, Animal; Drug Therapy, Combination; fas Receptor; Fluorobenzenes; Lithium Carbonate; meta-Aminobenzoates; Mice; Mortality; Motor Activity; Motor Neurons; Oxidative Stress; Salicylates | 2007 |
Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus.
Topics: Amiloride; Animals; Aquaporin 1; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Kidney Medulla; Lithium; Lithium Carbonate; Male; Potassium; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium | 2008 |
Haloperidol-induced hyperactivity in neonatal rats: effect of lithium and stimulants.
Topics: Animals; Animals, Newborn; Dextroamphetamine; Disease Models, Animal; Female; Haloperidol; Humans; Hyperkinesis; Lithium; Lithium Carbonate; Male; Methylphenidate; Motor Activity; Rats; Rats, Inbred Strains | 1982 |
Lithium treatment restores clonidine's effect in an animal model of depression.
Topics: Animals; Clonidine; Depression; Disease Models, Animal; Drug Synergism; Growth Hormone; Lithium Carbonate; Male; Rats; Receptors, Serotonin; Time Factors | 1994 |
Lithium-pilocarpine status epilepticus in the immature rabbit.
Topics: Animals; Brain; Disease Models, Animal; Electroencephalography; Hippocampus; Lithium Carbonate; Neurons; Oxygen Consumption; Pilocarpine; Pyramidal Tracts; Rabbits; Seizures; Status Epilepticus | 1997 |
Porcine stress syndrome: an animal model for the neuroleptic malignant syndrome?
Topics: Animals; Brain; Bromocriptine; Disease Models, Animal; Haloperidol; Halothane; Hyperthermia, Induced; Lithium; Lithium Carbonate; Neuroleptic Malignant Syndrome; Pilot Projects; Receptors, Dopamine; Swine; Swine Diseases | 1990 |